CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 28, 2008--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Thursday, May 1, 2008 at 1:40 p.m. EDT. The presentation will be webcast from the Ritz-Carlton, Key Biscayne, Florida and may be accessed under the investor relation's tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.
CONTACT: Alkermes, Inc.
Debra Koufos, 617-583-6220
Associate, Corporate Communications
SOURCE: Alkermes, Inc.